Organometallics
Article
(yellow solid; E isomer): 0.131 g (43%). 1H NMR (400 MHz,
CDCl3): δ 9.47 [s, 1H, 3J(Pt−H) = 54.4, CHN]; 7.58 [dd, 2H, 4J(F−
3J(H−Pt) = 36.0, 2H, NCH2]; 2.85 [m, 8H, NMe2 + CH2NMe2]; 2.02
[qi, 2H, 3J(H−H) = 5.3, CH2CH2CH2]. 19F NMR (376.5 MHz,
CDCl3): δ −104.07 [m, 1F]. 13C NMR (100.6 MHz, CDCl3): δ 27.23
[3J(C−Pt) = 31.0, CH2CH2CH2]; 50.19 [NMe2]; 57.50 [2J(C−Pt) =
3
3
3
H) = 5.6, J(H−H) = 8.0, H2,6]; 7.19 [t, 2H, J(H−F) = J(H−H) =
3
8.4, H3,5]; 4.04 [t, 2H, J(H−H) = 6.0, CH2N]; 3.13 [s, 6H, NMe2];
2.69 [t, 2H, 3J(H−H) = 6.0, H7]. 19F-NMR (376,5 MHz, CDCl3): δ −
104.40 [m]. ESI (+)-MS: 478.06 [M + NH4]+ ; 483.02 [M + Na]+.
Anal. Found18 (calcd for C11H15Cl2FN2Pt): C, 28.5 (28.71); H, 3.1
(3.29); N, 6.1 (6.10).
2
38.0, NCH2]; 64.12 [CH2NMe2]; 110.37 [d, J(C−F) = 24.1, C3];
2
3
121.17 [d, J(C−F) = 20.1, C5]; 129.01 [d, J(C−F) = 10.1, C2];
141.00 [d, 4J(C−F) = 2.0, C1]; 146.00 [d, 3J(C−F) = 7.0, C6]; 163.54
[d, 1J(C−F) = 257.5, C4]; 175.13 [2J(C−Pt) = 96.6, CHN]. ESI
(+)-MS: 439.07 [M + H]+ ; 456.10 [M + NH4]+ . Anal. Found18
(calcd for C12H16ClFN2Pt): C, 32.0 (32.92); H, 3.7 (3.68); N, 6.3
(6.40).
[PtCl2{Me2N(CH2)3NCH(2,3,4-F3C6H)}] (2g). This compound was
prepared by following the same procedure from 0.319 g (0.71 mmol)
of cis-[PtCl2(dmso)2] and 0.173 g (0.71 mmol) of imine 1g. Yield (off-
1
white solid; mixture of E and Z isomers): 0.265 g (73%). H NMR
[PtCl{Me2N(CH2)2NCH(2-FC6H3)}] (3c). This compound was
prepared by following method 2 from 0.150 g of 2c and an equimolar
amount of sodium acetate and increasing the reaction time to 72 h.
(400 MHz, CDCl3): Z isomer δ 10.75 [m, 1H]; 9.04 [s, 1H, 3J(Pt−H)
= 120.0, CHN]; 7.29 [m, 1H]; {5.00 [m, 1H]; 4.26 [ddd, 1H, J(H−
H) = 11.2, 6.8, 2.0], CH2N}; {2.97 [s, 3H]; 2.86 [s, 3H], NMe2}; 2.73
1
Yield (orange solid): 44 mg (32%). H NMR (400 MHz, CDCl3): δ
1
4
3
[m, 2H,CH2NMe2]; {2.48 [m, 1H]; 2.01 [m, 1H], CH2CH2CH2}. H
8.62 [t, 1H, J(H−H) = 1.2, J(Pt−H) = 144.4, CHN]; 7.29 [m, 1H,
3
H3]; 7.23 [t, J(H−H) = 7.8, 1H, H4]; 6.47 [d, 1H, J(H−H) = 8.1,
3
3
NMR (400 MHz, CDCl3): E isomer δ 9.33 [s, 1H, J(Pt−H) = 56.0,
CHN]; 7.18−7.14 [m, 2H]; 4.03 [t, 2H, 3J(H−H) = 6.8, CH2N]; 3.00
[s, 6H, NMe2]; 2.73 [m, 2H, CH2NMe2]; 2.24 [m, 2H, CH2CH2CH2].
19F NMR (376,5 MHz, CDCl3): Z isomer δ −122.53 [m, 1F, F2]; −
H5]; 4.03 [td, 2H, J(H−H) = 6.0, J(H−H) = 1.2, J(H−Pt) = 34.4,
NCH2]; 3.10 [t, 2H, 3J(H−H) = 6.0, CH2NMe2]; 2.89 [s, 3J(H−Pt) =
14.8, 6H, NMe2]. 19F NMR (376.5 MHz, CDCl3): δ −108.14 [m, 1F].
ESI (+)-MS: 423.06 [M + H]+. Anal. Found18 (calcd for
C11H14ClFN2Pt): C, 31.9 (31.20); H, 4.0 (3.33); N, 6.1 (6.62).
[PtCl{Me2N(CH2)2NCH(4-FC6H3)}] (3d). This compound was
prepared by following method 2 from 0.150 g of 2d and the
equimolar amount of sodium acetate and increasing the reaction time
3
4
3
3
4
3
135.92 [dddd, 1F, J(F−F) = 22.6, J(F−F) = 15.2, J(F−H) = 7.6,
3J(F−H) = 3.8, F4]; − 158.97 [tdd, 1F, J(F−F) = 22.5, J(F−H) =
3
4
7.6, J(F−H) = 3.8, F3]. 19F NMR (376,5 MHz, CDCl3): E isomer: δ
5
3
−125.98 [m, 1F]; − 130.76 [m, 1F]; − 157.03 [tdd, 1F, J(F−F) =
18.8, J(F−H) = 7.6, J(F−H) = 3.8, F3]. ESI (+)-MS: 528.06 [M +
NH4]+; 475.05 [M − Cl]. Anal. Found (calcd) for C12H15Cl2F3N2Pt:
C, 28.0 (28.29); H, 3.0 (2.97); N, 5.7 (5.50).
4
5
1
to 72 h. Yield (orange solid): 40 mg (29%). H NMR (400 MHz,
CDCl3): δ 8.26 [s, 1H, 3J(Pt−H) = 141.2, CHN]; 7.41 [dd, 1H, 3J(F−
H) = 9.5, 4J(H−H) = 2.8, 3J(H−Pt) = 50.8, H5]; 7.24 [dd, 1H, 3J(H−
[PtCl2{Me2N(CH2)2NCH(2,3,4-F3C6H)}] (2h). This compound was
prepared by following the same procedure from 0.300 g (0.71 mmol)
of cis-[PtCl2(dmso)2] and 0.163 g (0.71 mmol) of imine 1h. Yield
(yellow solid; E isomer): 0.250 g (71%). 1H NMR (400 MHz,
H) = 8.0, J(H−F) = 5.6, H2]; 6.69 [td, 1H, J(F−H) = J(H−H) =
8.8, 4J(H−H) = 2.8, H3]; 4.06 [t, 2H, 3J(H−H) = 6.0, NCH2]; 3.11 [t,
2H, 3J(H−H) = 6.0, CH2NMe2]; 2.90 [s, 6H, NMe2]. 19F NMR (376.5
MHz, CDCl3): δ −102.92 [m, 1F]. ESI (+)-MS: 442.08 [M + NH4]+.
Anal. Found (calcd for C11H14ClFN2Pt): C, 30.7 (31.20); H, 3.4
(3.33); N, 6.7 (6.62).
4
3
3
3
CDCl3): δ 9.59 [s, 1H, J(Pt−H) = 48.0, CHN]; 7.34 [m, 1H]; 7.16
3
[m, 1H]; 3.87 [t, 2H, J(H−H) = 6.0, CH2N]; 3.13 [s, 6H, NMe2];
3
2.71 [t, 2H, J(H−H) = 6.0, H7]. 19F NMR (376,5 MHz, CDCl3): δ
3
4
3
[PtCl{Me2N(CH2)3NCH(2-OMe,3,4-F2C6H)}] (3g). This compound
was prepared following method 2 from 0.150 g of 2g and an equimolar
amount of sodium acetate and increasing the reaction time to 72 h.
−125.34 [dddd, 1F, J(F−F) = 18.8, J(F−F) = 15.0, J(F−H) = 7.5,
4J(F−H) = 3.8, F4]; − 128.91 [m, 1F, F2]; − 156.80 [tdd, 1F, 3J(F−F)
= 18.8, 4J(F−H) = 7.5, 5J(F−H) = 3.8, F3]. ESI (+)-MS: 514.04 [M +
NH4]+. Anal. Found (calcd for C11H13Cl2F3N2Pt): C, 26.0 (26.66); H,
3.2 (2.65); N, 5.3 (5.66).
1
Yield (orange solid): 40 mg (28%). H NMR (400 MHz, CDCl3): δ
8.59 [s, 1H, 3J(Pt−H) = 144.0, CHN]; 7.48 [dd, 1H, 3J(F−H) = 11.5,
5
4J(H−F) = 7.5, H5]; 4.01 [d, 3H, J(H−F) = 4.0, OMe]; 3.86 [t, 2H,
[PtCl{Me2N(CH2)3NCH(2-FC6H3)}] (3a). This compound was
obtained using method 1: a mixture of 0.250 g (0.59 mmol) of cis-
[PtCl2(dmso)2], 0.128 g (0.61 mmol) of imine 1a, and 0.050 g (0.61
mmol) of sodium acetate in 20 mL of dry methanol was refluxed for
48 h. Upon evaporation of the solvent to 10 mL, small amounts of
compound 2a and metallic platinum were filtered off, and the solution
was kept at 5 °C until crystallization was completed. The solid was
recrystallized in CH2Cl2/ MeOH to produce orange crystals. Yield: 22
mg (9%). Alternatively, compound 3a was prepared using method 2: a
mixture of 0.150 g (0.316 mmol) of compound 2a and 0.026 g (0.316
mmol) of sodium acetate in 20 mL of dry methanol was heated under
reflux for 48 h, and the solvent was evaporated to produce an oily
residue that was extracted with 5 mL of CH2Cl2. Methanol was added,
and the solution was kept at 5 °C until crystallization was completed.
Yield (orange solid): 60 mg (43.3%). 1H NMR (400 MHz, CDCl3): δ
3J(H−H) = 4.0, NCH2]; 2.83 [m, 8H, NMe2 + CH2NMe2]; 2.01 [m,
2H, CH2CH2CH2]. 19F NMR (376.5 MHz, CDCl3): δ −127.20 [dd,
3
3
4
1F, J(F−F) = 18.8, J(H−F) = 11.3, J(H−Pt) = 45.2, F4]; − 163.15
[ddq, 1F, J(F−F) = 18.8, J(H−F) = 7.5, J(H−F) = 3.8, F3]. HR-
ESI(+)-MS: m/z 486.0705, calcd for C13H18F2ClN2OPt [M + H]+
486.0718; 450.0937, calcd for C13H17F2N2OPt [M − Cl]+ 450.0951.
Anal. Found (calcd for C13H17F2ClN2OPt): C, 31.7 (32.16); H, 3.5
(3.53); N, 5.6 (5.77).
3
4
5
[PtCl{Me2N(CH2)2NCH(2-OMe,3,4-F2C6H)}] (3h). This compound
was prepared by following method 2 from 0.150 g of 2h and an
equimolar amount of sodium acetate and increasing the reaction time
1
to 72 h. Yield (orange solid): 42 mg (29%). H NMR (400 MHz,
CDCl3): δ 8.56 [s, 1H, 3J(Pt−H) = 140.0, CHN]; 7.17 [dd, 1H, 3J(F−
4
H) = 11.5, J(H−F) = 7.5, H5]; 4.06 [t, 2H, 3J(H−H) = 6.0, NCH2];
5
3
4
3
4.02 [d, 3H, J(H−F) = 3.2, OMe]; 3.01 [t, 2H, J(H−H) = 6.0,
8.67 [t, 1H, J(H−H) = 1.6, J(Pt−H) = 142.4, CHN]; 7.80 [d, 1H,
CH2NMe2]; 2.89 [s, 6H, J(Pt−H) = 15.2, NMe2]. 19F NMR (376.5
3
3J(H−H) = 8.0, J(H−Pt) = 40.0, H5]; 7.20 [m, 1H, H4]; 6.64 [ddd,
3
3
3
1H, J(H−H) = 0.8, J(H−H) = 8.0, J(F−H) = 10.0, H3]; 3.92 [m,
2H, NCH2]; 2.86 [m, 2H, CH2NMe2]; 2.85 [s, 6H, NMe2]; 2.04 [qi,
2H, 3J(H−H) = 5.2, CH2CH2CH2]. 19F NMR (376.5 MHz, CDCl3): δ
4
3
3
MHz, CDCl3): δ −126.14 [dd, 1F, J(F−F) = 18.8, J(H−F) = 12.0,
F4]; − 163.00 [ddq, 1F, J(F−F) = 18.8, J(H−F) = 7.5, J(H−F) =
3.8, F3]. ESI (+)-MS: 472.05 [M + H]+. Anal. Found (calcd for
C12H15F2ClN2OPt): C, 30.4 (30.57); H, 3.4 (3.21); N, 5.8 (5.94).
[PtMe{Me2N(CH2)3NCH(2-FC6H3)}] (4a). This compound was
obtained using the following procedure: 0.100 g (0.17 mmol) of
[Pt2Me4(μ-SMe2)2] and 0.072 g (0.34 mmol) of imine 1a were
dissolved in 20 mL of toluene, and the obtained solution was refluxed
for 1 h. The solvent was removed, and the residue was treated with
3
4
5
3
4
4
− 115.00 [dd, J(F−H) = 9.8, J(F−H) = 6.0, J(Pt−F) = 56.5]. ESI
(+)-MS: 438.08 [M + H]+ ; 461.06 [M + Na]+. Anal. Found18 (calcd
for C12H16ClFN2Pt): C, 33.1 (32.92); H, 3.7 (3.68); N, 6.1 (6.40).
[PtCl{Me2N(CH2)3NCH(4-FC6H3)}] (3b). This compound was
prepared by following method 2 from 0.150 g of 2b and an equimolar
1
amount of sodium acetate. Yield (orange solid): 50 mg (36.0%). H
1
NMR (400 MHz, CDCl3): δ 8.32 [t, 1H, 4J(H−H) = 1.6, 3J(Pt−H) =
141.6, CHN]; 7.72 [dd, 1H, 3J(H−Pt) = 40.0, 3J(F−H) = 10.0, 4J(H−
H) = 2.4, H5]; 7.24 [dd, 1H, 3J(H−H) = 8.0, 4J(H−F) = 4.0, H2]; 6.70
diethyl ether to give a red solid. Yield: 115 mg (79%). H NMR (400
3
MHz, CDCl3): δ 8.91 [s, 1H, J(Pt−H) = 60.4, CHN]; 7.44 [d, 1H,
3J(Pt−H) = 64.0, J(H−H) = 8.0, H5]; 7.17 [td, 1H, J(H−H) = 8.0,
3
3
[td, 1H, J(F−H) = J(H−H) = 8.5, J(H−H) = 2.4, H3]; 3.86 [m,
4J(H−F) = 6.4, H4]; 6.61 [ddd, 1H, 3J(F−H) = 10.4, J(H−H) = 8.0,
3
3
4
3
568
dx.doi.org/10.1021/om401111t | Organometallics 2014, 33, 561−570